Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

265651-18-1 - O-(N-Succinimidyl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, 98+% - N,N,N',N'-Tetramethyl-O-(N-succinimidyl)uronium hexafluorophosphate - HSTU - H54035 - Alfa Aesar

H54035 O-(N-Succinimidyl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, 98+%

CAS Number
265651-18-1
Synonyms
N,N,N',N'-Tetramethyl-O-(N-succinimidyl)uronium hexafluorophosphate
HSTU

Size Price ($) Quantity Availability
1g 36.72
5g 146.70
25g 560.41
Add to Cart Add to Quote Request View Item

O-(N-Succinimidyl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, 98+%

MDL
MFCD01863753

Chemical Properties

Formula
C9H16F6N3O3P
Formula Weight
359.21
Melting point
ca 220° dec.
Sensitivity
Moisture Sensitive
Solubility
Soluble in acetonitrile 0.5 g/mL.

Applications

Coupling reagent for peptide synthesis and the formation of other amides. Reactant for synthesis of liposomal contrast agents for magnetic resonance imaging, synthesis of protein labeling molecules, synthesis of thiol-reactive Cy5 derivatives.

Notes

Moisture sensitive. Store under inert gas. Store away from oxidizing agents, water/ moisture.

Literature References

H J Gruber; G Kada; B Pragl; C Riener; C D Hahn; G S Harms; W Ahrer; T G Dax; K Hohenthanner; H G Knaus. Preparation of thiol-reactive Cy5 derivatives from commercial Cy5 succinimidyl ester. Bioconjugate Chemistry. 2000, 11 (2), 161-166.

Sjoerd Hak; Honorius M H F Sanders; Prashant Agrawal; Sander Langereis; Holger Grüll; Henk M Keizer; Francesca Arena; Enzo Terreno; Gustav J Strijkers; Klaas Nicolay. A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging. European Journal of Pharmaceutics and Biopharmaceutics. 2009, 72 (2), 397-404.

GHS Hazard and Precautionary Statements

Hazard Statements: H315-H319-H335

Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.

Precautionary Statements: P261-P280-P305+P351+P338-P304+P340-P362-P312-P321-P405-P403+P233-P501a

Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves/protective clothing/eye protection/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Take off contaminated clothing and wash before reuse. Call a POISON CENTER or doctor/physician if you feel unwell. Specific treatment (see label). Store locked up. Store in a well-ventilated place. Keep container tightly closed. Dispose of contents/container in accordance with local/regional/national/international regulations.

Other References

Harmonized Tariff Code
2925.19
TSCA
No

Recommended

  • 36602

    Zinc granules, ACS, -20 mesh, 99.8% min
  • A13565

    Methanesulfonic acid, 98+%
  • J66125

    Defensin, human
  • H60897

    N-Ethyl-N-(4-methylbenzyl)-2-nitrobenzenesulfonamide, 97%
  • 36684

    4-Dimethylaminobenzaldehyde, ACS

Recently Viewed

Chemicals

Life Science

Metals & Materials

Catalysts

Analytical & Labware